Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Avoiding graft recooling after normothermic perfusion in liver transplantation

Official title: Avoiding Recooling After Normothermic Machine Perfusion in Liver Transplantation: a Multicenter, Parallel-group, Open-label, Non-inferiority Randomized Controlled Trial

Run by The Mediterranean Institute for Transplantation and Advanced Specialized Therapies · NCT07692490 · Data updated 2026-11-12

This trial tests whether skipping the cooling step before placing a donor liver into a recipient helps outcomes for adults receiving livers preserved with normothermic or sequential perfusion.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment170 (estimated)
SponsorThe Mediterranean Institute for Transplantation and Advanced Specialized Therapies
Academic / other
Locations14 sites (Ancona and 13 other locations)
StatusRecruiting
StartedJuly 7, 2026
Main results expectedOctober 6, 2028
Study endsOctober 6, 2028
Registry record updatedOctober 28, 2026
Trial IDNCT07692490 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (18+) listed for primary liver transplantation with grafts preserved by normothermic or SHNMP perfusion at participating centers.

Probably not a fit

Patients receiving grafts not affected by the recooling approach or whose injury risk is unrelated to perfusion temperature may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter, open-label study compares two implantation approaches in adult liver transplant recipients: standard recooling with cold preservation solution versus immediate reperfusion without recooling using a room-temperature albumin flush. It is a randomized, parallel-group, non-inferiority design to see if avoiding recooling is not worse for early graft function. The primary endpoint is the occurrence of Early Allograft Dysfunction by Olthoff criteria. Participants are adults listed for primary liver transplantation with grafts preserved by normothermic machine perfusion or SHNMP, randomized 1:1 to the two strategies. The study analyzes early post-transplant outcomes and safety across multiple centers.

Why it matters

Potential benefit: If successful, avoiding recooling could reduce temperature-related injury and improve early graft function after liver transplantation.

How similar studies have gone: Prior data suggest temperature changes can influence ischemia-reperfusion injury, but this specific recooling strategy is novel in this context.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years.
* Listed for primary liver transplantation at the participating institution.
* Assigned a liver graft preserved with normothermic machine perfusion or sequential hypothermic- normothermic machine perfusion (SHNMP).
* Signed and dated informed consent prior study inclusion.

Exclusion Criteria:

* Pediatric patients (age \< 18 years)
* Patients undergoing re-transplantation (history of previous liver transplantation)
* Patients with acute liver failure
* Patients undergoing multi-organ transplantation (e.g., liver-kidney, liver-heart)
* Temporarily unconscious patients
* Patients unable to freely express consent.

Where it's running

  • IRCCS ISMETT - Istituto Mediterraneo per i Trapianti e le Terapie ad Alta Specializzazione
    Palermo, Italy
    Recruiting
  • Università Politecnica delle Marche, AUO delle Marche
    Ancona, Italy
    Not yet recruiting
  • Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari - Ospedale Giovanni XXIII
    Bari, Italy
    Not yet recruiting
  • ASST Papa Giovanni XXIII
    Bergamo, Italy
    Not yet recruiting
  • IRCCS Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Italy
    Not yet recruiting
  • Ospedale Università Policlinico San Martino - IRCCS
    Genova, Italy
    Not yet recruiting
Show 8 more locations
  • Università di Modena e Reggio Emilia
    Modena, Italy
    Not yet recruiting
  • Azienda Ospedale-Università di Padova
    Padova, Italy
    Not yet recruiting
  • Azienda Ospedaliero Universitaria Pisana
    Pisa, Italy
    Not yet recruiting
  • Fondazione PTV - Policlinico Tor Vergata
    Roma, Italy
    Not yet recruiting
  • Azienda Ospedaliera San Camillo Forlanini
    Roma, Italy
    Not yet recruiting
  • Azienda Ospedaliero-Universitaria Policlinico Umberto I - Sapienza Università di Roma
    Roma, Italy
    Not yet recruiting
  • Fondazione Policlinico "Agostino Gemelli" IRCCS
    Roma, Italy
    Not yet recruiting
  • Azienda Ospedaliera Universitaria Integrata Verona
    Verona, Italy
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.